POSC (Positron) Cyclically Adjusted Revenue per Share: $4.15 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POSC Positron Corp POSC
22 GF Score
Price $1.79
GF Value $0.22
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Positron Cyclically Adjusted Revenue per Share?

Positron POSC 22 Cyclically Adjusted Revenue per Share is $4.15 as of Jun. 2026. GuruFocus rates POSC with a GF Score™ of 22/100 and a GF Value™ of $0.22 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Positron's adjusted revenue per share for the three months ended in Jun. 2026 was $0.003. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $4.15 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -15.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -21.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -22.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Positron was -11.60% per year. The lowest was -44.80% per year. And the median was -26.30% per year.

As of today (2026-09-15), Positron's current stock price is $1.79. Positron's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $4.15. Positron's Cyclically Adjusted PS Ratio of today is 0.43.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Positron was 0.55. The lowest was 0.33. And the median was 0.42.


Positron  (OTCPK:POSC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Positron's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.79/4.15
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Positron was 0.55. The lowest was 0.33. And the median was 0.42.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Positron Cyclically Adjusted Revenue per Share Related Terms


Positron Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Positron's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Positron Cyclically Adjusted Revenue per Share Chart

Positron Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.67 7.71 5.20 0.00 0.00

Positron Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec24 Mar25 Jun25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 6.14 0.00 5.03 4.15

POSC vs XTNT, COCH, SRTS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Positron's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Positron Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Positron's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Positron's Cyclically Adjusted PS Ratio falls into.


POSC
22GF Score
Positron Corp POSC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Positron Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Positron's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.003/333.9520*333.9520
=0.003

Current CPI (Jun. 2026) = 333.9520.

Positron Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200706 3.621 208.352 5.804
200709 2.336 208.490 3.742
200712 2.603 210.036 4.139
200803 1.602 213.528 2.505
200806 2.645 218.815 4.037
200809 0.982 218.783 1.499
200812 1.379 210.228 2.191
200903 0.859 212.709 1.349
200906 0.668 215.693 1.034
200909 0.333 215.969 0.515
200912 0.570 215.949 0.881
201003 0.455 217.631 0.698
201006 0.645 217.965 0.988
201009 0.536 218.439 0.819
201012 1.129 219.179 1.720
201103 1.464 223.467 2.188
201106 1.530 225.722 2.264
201109 0.242 226.889 0.356
201112 0.149 225.672 0.220
201203 0.342 229.392 0.498
201206 0.390 229.478 0.568
201209 0.109 231.407 0.157
201212 0.104 229.601 0.151
201303 0.102 232.773 0.146
201306 0.119 233.504 0.170
201309 0.097 234.149 0.138
201312 0.131 233.049 0.188
201403 0.126 236.293 0.178
201406 0.041 238.343 0.057
201409 0.037 238.031 0.052
201412 0.019 234.812 0.027
201503 0.025 236.119 0.035
201506 0.023 238.638 0.032
201509 0.021 237.945 0.029
202412 0.000 315.605 0.000
202503 0.004 319.799 0.004
202506 0.004 322.561 0.004
202512 0.000 324.054 0.000
202603 0.003 330.213 0.003
202606 0.003 333.952 0.003

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $4.15 mean?
Positron (POSC) has a Cyclically Adjusted Revenue per Share of $4.15 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Positron and its competitors.
Is Positron's Cyclically Adjusted Revenue per Share too high?
Positron's current Cyclically Adjusted Revenue per Share is $4.15. Overall, Positron has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Positron's Cyclically Adjusted Revenue per Share compare to XTNT and COCH?
Positron's Cyclically Adjusted Revenue per Share of $4.15 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Positron and its competitors. Positron's current Cyclically Adjusted Revenue per Share is $4.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Positron stock overvalued right now?
Based on GuruFocus' analysis, Positron (POSC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.22, compared to a current price of $1.79 — trading 713.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $4.15. Positron's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Positron (POSC), the current Cyclically Adjusted Revenue per Share is $4.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Positron (POSC) Overvalued in 2026?

Based on GuruFocus' analysis, Positron stock appears to be overvalued. The current stock price of $1.79 is trading 713.6% above its estimated GF Value™ of $0.22. GuruFocus considers Positron to be Significantly Overvalued.

Key valuation signals for POSC:

  • Cyclically Adjusted Revenue per Share: $4.15
  • GF Value™: $0.22 vs. price of $1.79 (713.6% above fair value)
  • GF Score™: 22/100 with 6 warning signs

No single metric tells the full story. See the POSC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Positron Business Description

Address 3784 Commerce Court, Suite 100, North Tonawanda, NY, USA, 14120
Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. By combining proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, & a focus on operational efficiency, Positron makes advance diagnostic imaging more accessible & sustainable for hospitals, outpatient centers, & physician practices. The company focused on advancing positron emission tomography imaging through the development, manufacture, & commercialization of PET & PET-computed tomography imaging systems.
22GF Score

Get the complete analysis for POSC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.79
Price
$0.22
GF Value